Coronary Artery Disease Clinical Trials in York, Pennsylvania
5 studies are recruiting for coronary artery disease in York, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Wellspan York Hospital, York, Pennsylvania
- Locations
- 19 in total
- Run by
- Supira Medical
-
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…
- Stage
- Not phased
- Ages
- Any age
- Site
- WellSpan Heart & Vascular, York, Pennsylvania
- Locations
- 48 in total
- Run by
- Minneapolis Heart Institute Foundation
-
Virtue® SAB in the Treatment of Coronary ISR Trial
A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- WellSpan Health, York, Pennsylvania
- Locations
- 15 in total
- Run by
- Orchestra BioMed, Inc
-
SELUTION 4 De Novo Small Vessel IDE Trial
Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- WellSpan York Hospital, York, Pennsylvania
- Locations
- 70 in total
- Run by
- M.A. Med Alliance S.A.
-
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Heart and Vascular Research at WellSpan Health, York, Pennsylvania
- Locations
- 18 in total
- Run by
- Kardion Inc
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.